CSIMarket
 
Stryker Corp  (SYK)
Other Ticker:  
 
 
Price: $236.1000 $-3.93 -1.637%
Day's High: $239.76 Week Perf: -3.79 %
Day's Low: $ 237.17 30 Day Perf: -0.41 %
Volume (M): 56 52 Wk High: $ 250.02
Volume (M$): $ 13,230 52 Wk Avg: $205.51
Open: $239.70 52 Wk Low: $124.54



 Market Capitalization (Millions $) 91,087
 Shares Outstanding (Millions) 386
 Employees 40,000
 Revenues (TTM) (Millions $) 14,351
 Net Income (TTM) (Millions $) 1,599
 Cash Flow (TTM) (Millions $) -1,394
 Capital Exp. (TTM) (Millions $) 487

Stryker Corp
Stryker Corporation is a leader in the worldwide orthopaedic market and is one of the world's largest medical device companies. Stryker delivers results through a wide range of capabilities including joint replacements, trauma, spine and micro implant systems, orthobiologics, powered surgical instruments, surgical navigation systems and endoscopic products as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a leading orthopaedic surgeon and the inventor of several orthopaedic products.


   Company Address: 2825 Airview Boulevard, Kalamazoo, 49002 MI
   Company Phone Number: 385-2600   Stock Exchange / Ticker: NYSE SYK
   SYK is expected to report next financial results on April 20, 2021. Next quarterly dividend pay out on May 03, 2021.


Customers recorded net loss Customers recorded net loss



• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX        1.54% 
PDCO   -3.21%    
MDT   -1.13%    
CAH        3.64% 
DHR   -6.01%    
JNJ   -1.16%    
• View Complete Report
   



Sanofi

Sanofi announced financial time frame ending Dec 31 2020 operating income of $15837.92 millions

Although revenue fell in the financial time frame ending Dec 31 2020, company managed to grow its earnings per share, earnings per share soared by 338.12 % to $10.94 per share while Sales fell by -0.7% to $41.85 billions, year on year.

From the preceding quarter, from $0.00 per share and from $0.00 millions.
In the fiscal year 2020, Sanofi reported Sales of $41.85 billions and net income of $13.83 billions.

Eps surged by 338.12 % to $10.94 per share from $2.50 in the previous fiscal year, while Sales decreased by -0.7 % from $42.15 billions a year ago.

Catalyst Biosciences Inc

Logged a Loss but Revenues Unchanged

In the fourth quarter of 2020 Catalyst Biosciences Inc lost money of $-0.85 per share compared to $-1.13 a year ago and increased losses from $-0.73 per share from the previous quarter.

Sales remained unchanged to $2.03 millions from $0.00 millions in the same quarter a year ago and sequentially Sales doubled by 127.44 % from $0.89 millions.
Catalyst Biosciences Inc reported net loss of $-56.24 millions and Sales of $20.95 millions for the fiscal year 2020.

Company has decreased loss per share to $-2.93 from $-4.60 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

Westwood Holdings Group Inc

Rasults hit by impairment charges

Westwood Holdings Group Inc see its third quarter of -104 results, effected by $3.40 million impairment of assets, company reports $-1.31 loss per share.

In contrast to the second quarter Sales decreased by -2.65% from $15.88 millions and increased losses from $-0.33 per share.

W and t Offshore Inc

W And T Offshore Inc revalues its goodwill and intangible assets, by taking $22.52 million charge in the fourth quarter of 2020

W And T Offshore Inc revalues its goodwill and intangible assets, by taking $22.52 million charge in the fourth quarter of 2020

Sales faded by -37.62% to $94.75 millions from $151.89 millions in the same quarter a year ago and sequentially Sales surged by 30.66 % from $72.52 millions.
In the fiscal year 2020, W And T Offshore Inc reported Sales of $346.63 millions and net income of $37.79 millions.

Income per share faded by -50 % to $0.26 per share from $0.52 in the previous fiscal year, while Sales Tumbled by -35.2 % from $534.90 millions a year ago.

Conformis inc

Loss on Weak Sales

In the most recent fiscal period Conformis Inc lost money of $-0.08 per share compared to $-0.08 a year ago and improved from $-0.09 per share from the previous quarter.

Sales declined in double digits by -16.05% to $16.70 millions from $19.89 millions in the same quarter a year ago and sequentially Sales increased by 3.57 % from $16.12 millions.
Conformis Inc reported net loss of $-24.29 millions and Sales of $68.76 millions for the fiscal year 2020.

Company has decreased loss per share to $-0.34 from $-0.44 in the previous fiscal year, while Sales deteriorated by -11.19 % from $77.43 millions a year ago.






 

Stryker's Segments
 
Hips
 Segment    12.69 % of total Revenue
Knees
 Segment    13.72 % of total Revenue
Trauma & Extremities
 Segment    13.14 % of total Revenue
Total Reconstructive
 Segment    42.11 % of total Revenue
Surgical equipment
 Segment    14.83 % of total Revenue
Endoscopic & communications systems
 Segment    13.88 % of total Revenue
Patient handling & emergency equipment
 Segment    8.06 % of total Revenue
Total MedSurg
 Segment    38.97 % of total Revenue
Spine
 Segment    7.56 % of total Revenue
Neurotechnology
 Segment    11.36 % of total Revenue
Total Neurotechnology & Spine
 Segment    18.93 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Stryker does not provide revenue guidance.

Earnings Outlook
Conformis inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 67.78 %
Asia Pacific 14.14 %
Europe 14.17 %
Other 3.91 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FSLR's Profile

Stock Price

FSLR's Financials

Business Description

Fundamentals

Charts & Quotes

FSLR's News

Suppliers

FSLR's Competitors

Customers & Markets

Economic Indicators

FSLR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071